NCT07104942 Effect of Expiratory Muscle Strength in Patients With Bronchiectasis
| NCT ID | NCT07104942 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nisanur Tutuş |
| Condition | Bronchiectasis |
| Study Type | OBSERVATIONAL |
| Enrollment | 64 participants |
| Start Date | 2025-08 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 64 participants in total. It began in 2025-08 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates the relationship between expiratory muscle strength and clinical outcomes such as disease severity, hospital admissions, and quality of life in individuals with bronchiectasis.
Eligibility Criteria
Inclusion Criteria: * Having a diagnosis of non-cystic fibrosis bronchiectasis * Without an acute infection at the time of assessment (confirmed by medical history, serum C-reactive protein levels, chest X-ray and/or HRCT). * Being between 18 and 65 years of age Exclusion Criteria: * Myopathies * Stroke (Cerebrovascular accident - CVA) * Pregnancy * Unstable cardiac disease
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07104942 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Bronchiectasis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07104942 currently recruiting?
Yes, NCT07104942 is actively recruiting participants. Contact the research team at nisanurtutuss@gmail.com for enrollment information.
Where is the NCT07104942 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07104942 clinical trial?
NCT07104942 is sponsored by Nisanur Tutuş. The trial plans to enroll 64 participants.